Complete financial analysis of Together Pharma Ltd (TGPHF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Together Pharma Ltd, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- G.M. Breweries Limited (GMBREW.NS) Income Statement Analysis – Financial Results
- Zhejiang Meida Industrial Co., Ltd. (002677.SZ) Income Statement Analysis – Financial Results
- Top Glove Corporation Bhd. (TGLVY) Income Statement Analysis – Financial Results
- PetroChina Company Limited (PTR) Income Statement Analysis – Financial Results
- Interroll Holding AG (IRRHF) Income Statement Analysis – Financial Results
Together Pharma Ltd (TGPHF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.together-pharma.com
About Together Pharma Ltd
Together Pharma Ltd, through its subsidiaries, engages in growing, production, storage, and distribution of medical cannabis products in Israel. The company is based in Ashkelon, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 91.01M | 31.23M | 12.03M | 11.22M | 0.00 | 0.00 | 0.00 | 0.00 | 12.11M | 7.59M | 1.19M | 37.34K |
| Cost of Revenue | 56.38M | 37.12M | 14.20M | 17.06M | 1.42M | 86.00K | 10.79K | 15.36K | 4.90M | 4.69M | 807.95K | 0.00 |
| Gross Profit | 34.62M | -5.89M | -2.17M | -5.84M | -1.42M | -86.00K | -10.79K | -15.36K | 7.21M | 2.90M | 381.44K | 37.34K |
| Gross Profit Ratio | 38.04% | -18.85% | -18.07% | -52.03% | 0.00% | 0.00% | 0.00% | 0.00% | 59.56% | 38.21% | 32.07% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 42.38K | 222.10K | 2.03M | 1.56M | 2.22M |
| General & Administrative | 7.08M | 7.58M | 8.66M | 10.91M | 13.69M | 3.70M | 51.00K | 2.73M | 2.45M | 5.38M | 2.68M | 903.56K |
| Selling & Marketing | 5.45M | 4.03M | 889.00K | 378.00K | 69.00K | -86.00K | 2.22M | -9.95K | 576.68K | 2.09M | 839.16K | 690.73K |
| SG&A | 12.53M | 11.61M | 10.99M | 11.29M | 13.76M | 3.70M | 51.00K | 2.73M | 3.03M | 7.48M | 3.52M | 2.02M |
| Other Expenses | 0.00 | -2.27M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 12.53M | 13.42M | 9.03M | 11.16M | 14.48M | 145.78M | 51.00K | 2.00M | 3.35M | 8.60M | 4.88M | 13.05M |
| Cost & Expenses | 68.91M | 50.54M | 23.23M | 28.22M | 15.90M | 145.78M | 51.00K | 2.00M | 3.35M | 13.29M | 5.69M | 13.05M |
| Interest Income | 23.42M | 17.02M | 3.91M | 2.97M | 765.00K | 4.11M | 0.00 | 265.84K | 487.06K | 171.44K | 13.87K | 41.07K |
| Interest Expense | 0.00 | 17.04M | 14.87M | 11.87M | 6.27M | 4.13M | 348.91K | 234.16K | 854.75K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 5.52M | 5.40M | 5.32M | 3.93M | 1.42M | 86.00K | 51.00K | 204.20K | 471.48K | 397.42K | 13.87K | 14.94K |
| EBITDA | 27.62M | -14.37M | -6.14M | 20.56M | -13.96M | -3.62M | 17.00K | -3.04M | -2.78M | -6.21M | -4.69M | -4.19M |
| EBITDA Ratio | 30.35% | -46.01% | -51.04% | 183.15% | 0.00% | 0.00% | 0.00% | 0.00% | -22.93% | -81.87% | -394.46% | -11,210.00% |
| Operating Income | 22.09M | -19.77M | -11.46M | 16.63M | -15.38M | -3.70M | -51.00K | -3.24M | -3.25M | -6.61M | -4.71M | -4.20M |
| Operating Income Ratio | 24.28% | -63.31% | -95.27% | 148.18% | 0.00% | 0.00% | 0.00% | 0.00% | -26.83% | -87.11% | -395.63% | -11,250.00% |
| Total Other Income/Expenses | -20.56M | -16.56M | -3.66M | -2.47M | -1.29M | 2.23M | 0.00 | 1.51M | -588.37K | 1.08M | 221.93K | -8.77M |
| Income Before Tax | 1.54M | -36.33M | -15.12M | 14.16M | -16.66M | -149.89M | -51.00K | -1.73M | -3.84M | -5.53M | -4.48M | -12.97M |
| Income Before Tax Ratio | 1.69% | -116.33% | -125.69% | 126.20% | 0.00% | 0.00% | 0.00% | 0.00% | -31.68% | -72.93% | -376.97% | -34,740.00% |
| Income Tax Expense | 4.07M | 847.00K | -12.22M | 1.31M | -1.39M | -26.00K | 3.00M | 2.15M | -85.47K | 62.34K | 0.00 | 0.00 |
| Net Income | -4.32M | -33.52M | -13.78M | 7.15M | -15.28M | -149.86M | -34.00K | -1.73M | -3.84M | -5.47M | -4.48M | -12.97M |
| Net Income Ratio | -4.74% | -107.35% | -114.55% | 63.73% | 0.00% | 0.00% | 0.00% | 0.00% | -31.68% | -72.11% | -376.97% | -34,740.00% |
| EPS | -0.49 | -4.18 | -2.23 | 1.22 | -3.51 | -36.20 | -0.01 | -2.93 | -8.41 | -15.63 | -14.25 | -94.80 |
| EPS Diluted | -0.49 | -4.11 | -2.01 | 1.24 | -3.04 | -35.94 | -0.01 | -2.93 | -8.41 | -15.63 | -14.25 | -94.80 |
| Weighted Avg Shares Out | 8.79M | 8.02M | 6.18M | 5.87M | 4.35M | 4.14M | 2.91M | 591.23K | 456.36K | 349.89K | 314.58K | 136.82K |
| Weighted Avg Shares Out (Dil) | 8.79M | 8.15M | 6.85M | 5.77M | 5.02M | 4.17M | 2.91M | 591.23K | 456.36K | 349.89K | 314.58K | 136.83K |
No news found for: TGPHF
Source: https://incomestatements.info
Category: Stock Reports